The AI Platform for
Investment Researchers

Supercharge your investment research. Turn your data chaos into competitive edge

Ask about market patterns, correlations, or insights...
Deep Research
Deep Research enables multi-step research with advanced analysis

One Platform, All Your Data

Firmi connects to your internal data sources, 3rd party sources, and our own proprietary sources creating unified knowledge base for you, your team, and your firm.

Playground

Your AI Copilot for Equity Research

Playground turns unstructured data into concise, actionable insights helping you ask smarter questions and get sharper answers instantly.

Move from data to insight in seconds, not hours.

Tables

The Smart Layer for Portfolio Intelligence

Track, compare, and benchmark companies or sectors effortlessly. Tables unifies your financial, macro, and sector data so analysts can focus on strategy, not spreadsheets.

Your portfolio, reimagined as a live, intelligent dashboard.

ReportGen

Generate Professional-Grade Research in Minutes

From Investment Coverage Reports to Sector and Macro Analysis — ReportGen automates what once took weeks.

One click to transform your research into polished, ready-to-share reports.

Accelerate time to value

Delegate research tasks to Firmi like a domain-specific personal analyst that understands equity research

WITHOUT FIRMI
Time-Consuming
Searching:"Pharma companies ANDA approvals and FDA inspections"
Analyst downloads annual reports and quarterly statements from 12 NSE-listed pharma companies, manually tracking ANDA approvals, US FDA inspection outcomes, and R&D pipelines. Spends 15+ hours creating comparison tables and struggles to connect regulatory events with stock price movements.
Manual data extraction and analysis required
Traditional research takes days.
WITH FIRMI
Instant Analysis
Analyzing:"Which NSE pharma companies have received USFDA approvals for complex generics while maintaining clean inspection records in the past year?"
Firmi instantly processes regulatory filings and earnings data to report "Sun Pharma and Dr. Reddy's received 7 and 5 complex generics approvals respectively, with no Form 483 observations at key manufacturing facilities, driving 15% average US revenue growth."
Instant correlation of regulatory events with financial impact
Firmi delivers actionable insights.

Decode Complex Financial Documents with Firmi

Firmi uses State-of-the-art vision models specifically for your most complex documents, handling everything from massive tables, to tricky charts and graphs.

Chart Analysis

India electronic industry segment-wise forecasts

Scanning Data...

Scanning data for insights...